Experience With Ketanserin, A Serotonin (S2) Antagonist, in Longterm Treatment of Essential Hypertension
- 1 January 1984
- journal article
- clinical trial
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 6 (3), 743-751
- https://doi.org/10.3109/10641968409044035
Abstract
Ketanserin ia a quinazoline derivative which acts selectively on serotonin (S2) receptors. The compound has been shown to possess antihypertensive properties. BP and HR were measured blindly on 14 patients with essential hypertension during one year. Ketanserin 40 mg, once or twice daily, reduced BP (and HR to a slight extent) largely unchanged from 14 days after initiation of therapy. Response rate varied from 57-77% at the regular control visits. During the one year follow up period the reduction in supine SBP was 9 +/- 3% (p less than 0.001) and DBP was 12 +/- 1% (p less than 0.001). The only side effect was a slight sedation that passed with time. It is concluded that ketanserin is effective in the chronic treatment of hypertension and may offer a new alternative to existing pharmacotherapy.Keywords
This publication has 14 references indexed in Scilit:
- High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Ketanserin, a novel 5‐hydroxytryptamine antagonist: monotherapy in essential hypertension.British Journal of Clinical Pharmacology, 1983
- Mechanism of the Hypotensive Effect of KetanserinJournal of Cardiovascular Pharmacology, 1982
- Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agentJournal of Pharmacy and Pharmacology, 1982
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Haemodynamics in Essential HypertensionClinical Science, 1980
- Uptake of serotonin by human platelets and its relevance to CNS involvement in hypertensionLife Sciences, 1979
- 5-Hydroxytryptamine in the blood platelets of cirrhotic and hypertensive patientsCellular and Molecular Life Sciences, 1974
- Hemodynamics of HypertensionPhysiological Reviews, 1960